Cancer BiologybioRxivPreprint
Tumour-derived glucocorticoids amplify ROR1 and are exploited with glucocorticoid-resistant ROR1 CAR-T cells
Marc Philipp Schauer, Justus Weber, Peter Spieler…·Michael Hudecek
The paper shows that tumor-derived glucocorticoids increase ROR1 expression while suppressing T cell activity, and GC-resistant CAR-T cells can overcome this by preserving ROR1 expression in tumor cells.
3 citations